Ledger.Open graph →
SEC Form D · filed February 12, 2019

Rainier Therapeutics, Inc

Offering
$20.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN LEANDRO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

David L. Kabakoff · San Leandro, CADirectorMarten L. Steen · San Ramon, CADirectorChristian L. Richard · San Ramon, CADirectorGraeme M. Currie · San Leandro, CAExecJulie M. Eastland · San Leandro, CAExecFouad L. Azzam · San Ramon, CADirectorScott D. Myers · San Leandro, CAExec · DirectorJoseph L. Turner · San Ramon, CADirectorJoel L. Jean-Mairet · San Ramon, CADirectorSteve M. Abella · San Leandro, CAExecReal Estate L. Global · Road Town,, British Virgin IslandsExecAmanda Hall · Calgary, Alberta, CanadaExec · DirectorDavid Willard · San Jose, CAExecMartin Gross · Boone, IADirectorGreg L. Borowsky · New York, NYExecBrian L. Lee · New York, NYDirectorJustin Saliman · Los Angeles, CADirectorShaun L. Borowsky · New York, NYDirectorDavid Takes · Waverly, IADirectorBrothers L. Borowsky · New York, NYDirectorBrandon Mccarty · Durham, NCDirectorRobert Roy · Danvers, MADirectorWilliam J. Mulrow · Bethesda, MDDirectorDavid P. Paul · Bethesda, MDExecAlisa M. Mall · Bethesda, MDExecCharles E. Haldeman, Jr · Bethesda, MDDirectorKevin W. Reynolds · Bethesda, MDExec · DirectorW. M. Kelly · Bethesda, MDDirectorM. M. Banerjee · Bethesda, MDDirectorSteven A. Museles · Bethesda, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗